Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences

Journal of Virology

Volumn 68, Issue 11, 1994, Pages 7467-7481

  Korber, Bette T M ^a,b   Kunstman, Kevin J ^c   Patterson, Bruce K ^c   Furtado, Manohar ^c   McEvilly, Miranda M ^a   Levy, Robert ^c   Wolinsky, Steven M ^c,d  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b SANTA FE INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; ENVELOPE PROTEIN; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CLINICAL ARTICLE; DNA SEQUENCE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; ISOLATION PROCEDURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; VIRUS ISOLATION; VIRUS MORPHOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; BRAIN; CONSERVED SEQUENCE; GENE PRODUCTS, ENV; HIV-1; HUMAN; IN SITU HYBRIDIZATION; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; VIREMIA;

EID: 0028046638     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.68.11.7467-7481.1994     Document Type: Article

References (85)

1. Andeweg, A. C., P. Leeflang, A. D. M. E. Osterhaus, and M. L. Bosch. 1993. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation. J. Virol. 67: 3232-3239.
2. Berger, E. A., J. R. Sisler, and P. L. Earl. 1992. Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluable CD4-stimulated gp120 release. J. Virol. 66: 6208-6212.
3. Bergeron, L., N. Sullivan, and J. Sodroski. 1992. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J. Virol. 66:2389-2397.
4. Blahut, R. E. 1987. Information theory and statistics. Addison-Wesley, Reading, Mass.
5. Boyd, M. T., G. R. Simpson, A. J. Cann, M. A. Johnson, and R. A. Weiss. 1993. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J. Virol. 67:3649-3652.
6. Brew, B. J. 1993. HIV-1-related neurological disease. J. Acquired Immune Defic. Syndr. 6(Suppl. 1):S10-S15.
7. Budka, H., C. A. Wiley, P. Kleihues, J. Artigas, A. K. Asbury, E. S. Cho, D. R. Cornblath, M. C. D. Canto, U. DeGirolami, D. Dickson, L. G. Epstein, M. M. Esiri, F. Giangaspero, G. Gosztonyi, F. Gray, J. W. Griffin, D. Hennin, Y. Iwasaki, R. S. Janssen, R. T. Johnson, P. L. Lantos, W. D. Lyman, J. C. McArthur, K. Nagashima, N. Peress, C. K. Petito, R. W. Price, R. H. Rhodes, M. Rosenblum, G. Said, F. Scaravilli, L. R. Sharer, and H. V. Vinters. 1991. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1:143-152.
8. Cheng-Mayer, C., J. Homsy, L. A. Evans, and J. A. Levy. 1988. Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization. Proc. Natl. Acad. Sci. USA 85:2815-2819.
9. Cheng-Mayer, C., J. T. Rutka, M. L. Rosenblum, T. McHugh, D. P. Sites, and J. A. Levy. 1987. Human immunodeficiency virus can productively infect cultured human glial cells. Proc. Natl. Acad. Sci. USA 84:3526-3530.
10. Cheng-Mayer, C., C. Weiss, D. Seto, and J. A. Levy. 1989. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc. Natl. Acad. Sci. USA 86:8575-8579.
11. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
12. Coffin, J. M. 1992. Genetic diversity and evolution of retroviruses, Curr. Top. Microbiol. Immunol. 176:143-164.
13. de Jong, J. J., A. de Ronde, W. Keulen, M. Tersmette, and J. Goudsmit. 1992. Minimal requirements for the human immunodeficiency virus type 1 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66:6777-6780.
14. Delassus, S., R. Cheynier, and S. Wain-Hobson. 1992. Nonhomogeneous distribution of human immunodeficiency virus type 1 proviruses in the spleen. J. Virol. 66:5642-5645.
15. Dirks, R. W., R. P. M. van Gijlswilk, R. H. Tullis, A. B. Smit, J. Van Minnen, M. Van der Ploeg, and A. K. Rapp. 1990. Simultaneous detection of different mRNA sequences coding for neuropeptide hormones by double in situ hybridization using FITC-and biotin-labeled oligonucleotides. J. Histochem. Cytochem. 38: 467-473.
16. Dirks, R. W., R. P. M. van Gijlswilk, M. A. Vooljs, A. B. Smit, J. Bogerd, J. Van Minnen, A. K. Rapp, and M. Van der Ploeg. 1991. 3′-End fluorochromized and haptenized oligonucleotide as in situ hybridization probes for multiple, simultaneous RNA detection. Exp. Cell Res. 194:310-315.
17. Douglas, S. Unpublished data.
18. Dubois-Dolcq, M. Unpublished data.
19. Embretson, J., M. Zupancic, J. Beneke, M. Till, S. Wolinsky, J. Ribas, A. Burke, and A. Haase. 1993. Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single cell resolution. Proc. Natl. Acad. Sci. USA 90:357-361.
20. Epstein, L. G., C. Kuiken, B. M. Blumberg, S. Hartman, L. R. Sharer, M. Clement, and J. Goudsmit. 1991. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host determined quasispecies. Virology 180:583-590.
21. Faulkner, D. V., and A. Jurka. 1988. Multiple aligned sequence editor (MASE). Trends Biochem. Sci. 13:321-322.
22. Felsenstein, J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783-791.
23. Felsenstein, J. 1989. PHYLIP - phylogeny inference package (version 3.2). Cladistics 5:164-166.
24. Felsenstein, J. 1993. PHYLIP (phylogeny inference package) version 3.4. Department of Genetics, University of Washington, Seattle. Distributed by the author.
25. Fouchier, R. A. M., M. Groenink, N. A. Kootstra, M. Tersmette, H. G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Phenotype-associated sequence variation in the third variable region of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:3183-3187.
26. Freed, E. O., D. J. Myers, and R. Risser. 1991. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J. Virol. 65:190-194.
27. Freed, E. O., and R. Risser. 1991. Identification of conserved residues in the human immunodeficiency virus types 1 principal neutralizing determinant that are involved in fusion. AIDS Res. Human Retroviruses 7:807-811.
28. Gartner, S., P. Markovits, D. M. Markovitz, M. H. Kaplan, R. C. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
29. Goldstein, G. W., and A. L. Betz. 1986. The blood-brain barrier. Sci. Am. 255:74.
30. Groenink, M., R. A. M. Fouchier, S. Broersen, C. H. Baker, M. Root, A. B. van't Wout, H. G. Huisman, F. Miedema, M. Tersmette, and H. Schuitemaker. 1993. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 260:1513-1516.
31. Hillis, D. M., M. W. Allard, and M. M. Miyamoto. 1993. Analysis of DNA sequence data: phylogenetic inference. Methods Enzymol. 224:456-487.
32. Hillis, D. M., and J. J. Bull. 1993. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst. Biol. 42:182-189.
33. Holmes, E. C., L. Q. Zang, P. Simmonds, C. A. Ludlam, and A. J. Leigh Brown. 1992. Convergent and divergent sequence evolution in the surface envelope glycoprotein of the human immunodeficiency virus type 1 within a single patient. Proc. Natl. Acad. Sci. USA 89:4835-4839.
34. Hwang, A. S., and J. M. Coffin. 1992. How does variation count? Nature (London) 359:107-108.
35. Hwang, S. S., T. J. Boyle, H. K. Lyerly, and B. R. Cullen. 1991. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71-74.
36. Jordan, C., B. Watkins, C. Kufta, and M. Dubois-Dacq. 1991. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J. Virol. 65:736-742.
37. Keys, B., J. Karis, B. Fadeel, A. Valentine, G. Norkrans, L. Hagberg, and F. Chioda. 1993. V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 196:475-483.
38. Koenig, S., H. Gendelman, J. Orenstein, M. D. Canto, G. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. Martin, and A. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093.
39. Korber, B., and G. Myers. 1992. Signature patterns analysis: a method for assessing viral sequence relatedness. AIDS Res. Human Retroviruses 8:1549-1558.
40. Korber, B., S. Wolinsky, B. Haynes, K. Kuntsman, R. Levy, M. Furtado, P. Otto, and G. Myers. 1992. HIV-1 intrapatient sequence diversity in the immunogenic V3 region. AIDS Res. Human Retroviruses 8:1461-1465.
41. Korber, B. T. M., R. M. Farber, D. H. Wolpert, and A. S. Lapedes. 1993. Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis. Proc. Natl. Acad. Sci. USA 90:2176-2180.
42. Kowalski, M., L. Bergeron, T. Dorfman, W. Haseltine, and J. Sodroski. 1991. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. J. Virol. 65:281-291.
43. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Y. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
44. Kuiken, C. L., J. J. de Jong, E. Baan, W. Keulen, M. Tersmette, and J. Goudsmit. 1992. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of virus biological phenotype. J. Virol. 66: 4622-4627.
45. Kuiken, C. L., and B. T. M. Korber. 1994. Epidemiological significance of intra- and inter-person variation of HIV-1. AIDS 8:S73-S83.
46. Kuiken, C. L., G. Zwart, E. Baan, R. A. Coutinho, J. A. R. van den Hoek, and J. Goudsmit. 1993. Increasing antigenic and genetic diversity of the HIV-1 V3 domain in the course of the AIDS epidemic. Proc. Natl. Acad. Sci. USA 90:9061-9065.
47. Kusumi, K., B. Conway, S. Cunningham, A. Berson, C. Evans, A. K. N. Iversen, D. Colvin, M. V. Gallo, S. Coutre, E. G. Shpaer, D. V. Faulkner, A. deRonde, S. Volkman, C. Williams, M. S. Hirsch, and J. I. Mullins. 1992. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J. Virol. 66:875-885.
48. Lee, W.-R., W.-J. Syu, B. Du, M. Matsuda, S. Tan, A. Wolf, M. Essex, and T.-H. Lee. 1992. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89: 2213-2217.
49. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10381.
50. Levy, R. M., E. R. Russell, M. Yungbluth, D. F. Hidvegi, B. A. Brody, and M. C. Dal Canto. 1992. The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neurosurgery 30:186-190.
51. Li, X. L., T. Moudgil, H. V. Vinters, and D. D. Ho. 1990. CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. J. Virol. 64:1363-1387.
52. Li, Y., J. C. Kappes, J. A. Conway, R. W. Price, G. M. Shaw, and B. H. Hahn. 1991. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 65:3973-3985.
53. Li, Y., L. Luo, N. Rasool, and C. Y. Kang. 1993. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J. Virol. 67:584-588.
54. McKeating, J. A., J. Cordell, C. J. Dean, and P. Balfe. 1992. Synergistic interactions between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 191:732-742.
55. McNearney, T., P. Westervelt, B. J. Thielan, D. B. Trowbridge, J. Garcia, R. Whittier, and L. Ratner. 1990. Limited sequence heterogeneity among biologically distinct human immunodeficiency virus type 1 isolates from individuals involved in a clustered infectious outbreak. Proc. Natl. Acad. Sci. USA 87:1917-1921.
56. Milich, L., B. Margolin, and R. Swanstrom. 1993. V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J. Virol. 67:5623-5634.
57. Moore, J. P., and P. L. Nara. 1991. The role of the V3 loop of gp120 in HIV infection and binding. AIDS 5:s31-s33.
58. Myers, G., B. Korber, S. Wain-Hobson, R. F. Smith, and G. N. Pavlakis. 1993. Human retroviruses and AIDS 1993. Los Alamos National Laboratory for Theoretical Biology and Biophysics, Los Alamos, N. Mex.
59. Myers, G., and R. Lenroot. 1992. HIV glycosylation: what does it portend? AIDS Res. Human Retroviruses 8:1459-1460.
60. O'Brian, W. A., Y. Koyanagi, A. Namazie, J. Zhao, A. Diagne, K. Idler, and I. S. Y. Chen. 1990. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 which do not include the CD4 binding domain. Nature (London) 348:69-73.
61. Pang, S., H. V. Vinters, T. Akashi, W. A. O'Brien, and I. S. Y. Chen. 1991. HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J. Acquired Immune Defic. Syndr. 4:1082-1092.
62. Pinter, A., W. J. Honnen, and S. A. Tilley. 1993. Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites. J. Virol. 67:5692-5697.
63. Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes in the human immunodeficiency virus envelope glycoproteins by soluable CD4 binding. J. Exp. Med. 174:407-415.
64. Sharer, L. R. 1992. Pathology of HIV-1 infection of the central nervous system. J. Neuropathol. Exp. Neurol. 51:3-11.
65. Sharpless, N. E., W. A. O'Brien, E. Verdin, C. V. Kufta, I. S. Chen, and M. Dubois-Dalcq. 1992. Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J. Virol. 66:2588-2593.
66. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1992. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89:9434-9438.
67. Smith, R. F., and T. F. Smith. 1990. Automatic generation of primary sequence patterns from sets of related protein sequences. Proc. Natl. Acad. Sci. USA 87:118-122.
68. Smith, R. F., and T. F. Smith. 1992. Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modeling. Protein Eng. 5:35-411.
69. Stamatatos, L., and C. Cheng-Mayer. 1993. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J. Virol. 67:5635-5639.
70. Steuler, H., B. Storch-Hagenlocher, and B. Wildemann. 1992. Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid. AIDS Res. Human Retroviruses 8: 53-59.
71. Swofford, D. 1993. PAUP (phylogenetic analysis using parsimony) version 3.1. Center for Biodiversity, Illinois Natural History Survey, Champaign, Ill.
72. Swofford, D. L., and G. J. Olson. 1991. Phylogeny reconstruction, p. 411-566. In D. M. Hillis and C. Moritz (ed.), Molecular systematics. Sinauer Associates, Inc., Sunderland, Mass.
73. Tornatore, C., A. Nath, K. Amemiya, and E. O. Major. 1991. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J. Virol. 65:6094-6100.
74. Vartanian, J. P., A. Meyerhans, B. Asjo, and S. Wain-Hobson. 1991. Selection, recombination, and G→A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65:1779-1788.
75. Wain-Hobson, S. 1989. HIV genome variability in vivo. AIDS 3(Suppl. 1):S13-S18.
76. Watkins, B. A., H. H. Dorn, W. B. Kelly, R. C. Armstrong, B. Potts, F. Michaels, C. V. Kufta, and M. Dubois-Dulcq. 1990. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249:549-553.
77. Weber, J., P. Clapham, J. McKeating, M. Stratton, E. Robey, and R. Weiss. 1989. Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 as receptor. J. Gen. Virol. 70:2653-2260.
78. Westervelt, P., H. E. Gendelman, and L. Ratner. 1991. Identification of a determinant within the human immunodeficiency virus type 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. USA 88:3097-3101.
79. Westervelt, P., D. B. Trowbridge, L. G. Epstein, B. M. Blumberg, Y. Li, B. H. Hahn, G. M. Shaw, R. W. Price, and L. Ratner. 1992. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66:2577-2582.
80. Wiley, C., R. Schrier, J. Nelson, P. Lampert, and M. Oldstone. 1986. Cellular localization of HIV infection within brains of AIDS patients. Proc. Natl. Acad. Sci. USA 83:7089-7093.
81. Wolfs, T. F. W., G. Zwart, M. Bakker, and J. Goudsmit. 1992. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189:103-110.
82. Wolinsky, S. M., C. M. Wike, B. Korber, C. Hutto, W. P. Parks, L. L. Rosenblum, K. J. Kunstman, M. R. Furtado, and J. Munoz. 1992. Selective transmission of human immunodeficiency virus type 1 variants from mothers to infants. Science 255:1134-1137.
83. Wyatt, R., M. Thali, S. Tilley, A. Pinter, M. Posner, D. Ho, J. Robinson, and J. Sodroski. 1992. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region. J. Virol. 66:6997-7004.
84. Zhang, L. Q., P. MacKenzie, A. Cleland, E. C. Holmes, A. J. Leigh Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
85. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181.